Comparably, dual targeting of human pancreatic adenocarcinomas (BXPC-3 cell line) in an orthotopic mouse model was achieved with a 64Cu-NOTA-conjugated heterodimer of anti-tissue factor and anti-endoglin Fab [56]. This evidence concerns the gene F3 and pancreatic adenocarcinoma.